Finally, our findings indicate that Wnt5b-Ror2 signaling in MPs can serve as a suitable diagnostic and therapeutic target for sarcopenia and various muscular diseases, including DMD. This evidence concerns the gene WNT5B and Duchenne muscular dystrophy.